ciqorin 100 mg mīkstās kapsulas
teva pharma b.v., netherlands - ciklosporīns - mīkstās kapsulas - 100 mg
gracial tabletes
aspen pharma trading ltd., ireland - desogestrelum, ethinylestradiolum - tablete
cleodette 0,02 mg/3 mg apvalkotās tabletes
actavis group ptc ehf., iceland - ethinylestradiolum, drospirenonum - apvalkotās tabletes - 0,02 mg/3 mg
brilleve 75 mikrogrami/20 mikrogrami tabletes
sandoz d.d., slovenia - gestodenum, ethinylestradiolum - tablete - 75 µg/20 µg
sandimmun neoral 25 mg mīkstās kapsulas
novartis baltics, sia, latvia - ciklosporīns - kapsula, mīkstā - 25 mg
sandimmun neoral 50 mg mīkstās kapsulas
novartis baltics, sia, latvia - ciklosporīns - kapsula, mīkstā - 50 mg
brilleve 75 mikrogrami/30 mikrogrami tabletes
sandoz d.d., slovenia - gestodenum, ethinylestradiolum - tablete - 75 µg/30 µg
iamna 60/15 mikrogramu apvalkotās tabletes
sandoz d.d., slovenia - gestodenum, ethinylestradiolum - apvalkotā tablete - 60 µg/15µg
tadalafil accord 20 mg apvalkotās tabletes
accord healthcare b.v., netherlands - tadalafils - apvalkotā tablete - 20 mg
braftovi
pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastiski līdzekļi - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.